Scientists have developed a universal vaccine against influenza A

Scientists from the U.S. and the UK the successful completion of the first phase of clinical trials with a vaccine capable of long-term protection against all types of human influenza virus type A. The new vaccine, called Acamflu-A, causes that the body of. the immune response against the protein of the human influenza A virus called M2e Previously created vaccines administered immune response to viral proteins, hemagglutinin and neuraminidase, which mutate from season to season, the need not to create new and novel vaccines. An important step in the search for lasting solutions to the pandemic influenza (pandemic through modifications of the influenza virus type A, and in all these modifications M2e protein is unchanged, which means that the new vaccine will be recognized.) Has been shown in mice have been used to reduce the mortality of bird flu after treatment Acamflu-A. According to the World Health Organization, each year on the planet is dying from the flu 500 thousand up to a million people.